Oct 01, 2021 / 09:00PM GMT
Presentations
Oct 01, 2021 / 09:00PM GMT
=====================
Corporate Participants
=====================
* Kenneth T. Mills
REGENXBIO Inc. - President, CEO & Director
* Patrick J. Christmas
REGENXBIO Inc. - Senior VP & Chief Legal Officer
* Stephen Pakola
REGENXBIO Inc. - Senior VP & Chief Medical Officer
=====================
Conference Call Participants
=====================
* Alec Warren Stranahan
BofA Securities, Research Division - Associate
* Dane Vincent Leone
Raymond James & Associates, Inc., Research Division - Research Analyst
* Esther P. Rajavelu
UBS Investment Bank, Research Division - Analyst & Executive Director
* Huidong Wang
Barclays Bank PLC, Research Division - Research Analyst
* Luca Issi
RBC Capital Markets, Research Division - Research Analyst
* Mani Foroohar
SVB Leerink LLC, Research Division - MD of Genetic Medicines & Senior Research Analyst
* Vikram Purohit
Morgan Stanley,
Regenxbio Inc
(NAS:RGNX)
$
8.92
0.16 (1.83%)
Market Cap: 440.86 Mil
Enterprise Value: 228.13 Mil
PE Ratio: 0
PB Ratio: 1.26
GF Score: 65/100 Regenxbio Inc KOL Conference Call to Discuss RGX-314 Data Presentations Transcript
Oct 01, 2021 / 09:00PM GMT
Release Date Price:
$40.28
(-3.91%)
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot